Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597481 | SCV000702546 | uncertain significance | not provided | 2016-10-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000643432 | SCV000765119 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-09-20 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001332822 | SCV001525247 | uncertain significance | Dilated cardiomyopathy 1G | 2020-03-17 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Fulgent Genetics, |
RCV002506411 | SCV002817045 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-10-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004527673 | SCV004104812 | uncertain significance | TTN-related disorder | 2023-02-02 | criteria provided, single submitter | clinical testing | The TTN c.31821G>T variant is predicted to result in the amino acid substitution p.Lys10607Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.021% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-179554565-C-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Gene |
RCV000597481 | SCV005401400 | uncertain significance | not provided | 2024-05-13 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Missense variant in a gene in which most reported pathogenic variants are truncating/loss of function; Has not been previously published as pathogenic or benign to our knowledge; Located in a region of TTN within the I-band in which the majority of loss of function variants are significantly associated with autosomal dominant titinopathies (PMID: 27625338, 27869827) |